Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Sacher C, Hunzelmann N . Cicatricial pemphigoid (mucous membrane pemphigoid). Current and emerging therapeutic approaches. Am J Clin Dermatol 2005; 6: 93–103.
Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ et al. The first international consensus on mucous membrane pemphigoid. Arch Dermatol 2002; 138: 370–379.
Lim L, Suhler EB, Smith JR . Biologic therapies for inflammatory eye disease. Clin Experiment Ophthalmol 2006; 34: 365–374.
Heffernan MP, Bentley DD . Successful treatment of mucous membrane pemphigoid with infliximab. Arch Dermatol 2006; 142: 1268–1270.
Sacher C, Rubbert A, Konig C, Scharffetter-Kochanek K, Krieg T, Hunzelmann N . Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor-alpha antagonist etanercept. J Am Acad Dermatol 2002; 46: 113–115.
Author information
Authors and Affiliations
Additional information
HJ received a small contribution towards conference fees from Abbott. Other authors declare no competing interests
Rights and permissions
About this article
Cite this article
John, H., Whallett, A. & Quinlan, M. Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-α. Eye 21, 1434–1435 (2007). https://doi.org/10.1038/sj.eye.6702948
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6702948
This article is cited by
-
The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on
Eye (2017)
-
Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management
Drugs & Aging (2016)
-
Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom
Eye (2011)
